SCHEMBL311517

SCHEMBL311517

Cc1ccn2c(Cl)c(C[C@]3(C(C)(C)C)CCCCN3C(=O)O)nc2n1

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.31
AKT2 P31751 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2124400 0.82 SMN1; SMN2 (0.36)
SCHEMBL2122874 0.79 HCRTR1 (0.35)
SCHEMBL311401 0.78 PDE8B (0.32)
SCHEMBL2122677 0.78 CYP11B1 (0.36) AKT1AKT2
SCHEMBL2124331 0.74 ALDH1A1 (0.40)
SCHEMBL2512523 0.73 SMN1; SMN2 (0.38)
SCHEMBL2120890 0.72 HCRTR1 (0.33) AKT1AKT2
SCHEMBL2517435 0.72 SMN1; SMN2 (0.36)
SCHEMBL2123540 0.71 KMT2A (0.34)
SCHEMBL2124844 0.69 AKT1 (0.32) AKT1AKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093255-B2 Imidazo[1,2-A]pyrimidines as orexin receptor antagonists GLAXO GROUP LIMITED (GB) 2012-01-10 US disclosed